Strategies for prevention of infection after cardiac transplantation.
Infection remains a major cause of morbidity and mortality after cardiac transplantation. Most infections occur during the first few months after transplantation. Although late infection does occur, the risk of infection during maintenance immunosuppression is low in the absence of recurrent rejection that necessitates augmentation of suppression of the immune response. Before cardiac transplantation, the risk factors for infectious disease in potential candidates should be assessed. A detailed history of past infections should be elicited, and patients should be screened for the presence of active indolent infection. In addition, potential donors must be thoroughly assessed for organ-transmittable infection. Many common infections that may occur after cardiac transplantation can be prevented with the use of appropriate prophylactic regimens directed toward cytomegalovirus, Toxoplasma gondii, Pneumocystis carinii, and herpes simplex virus. Periodic surveillance serologic tests and cultures after cardiac transplantation facilitate early diagnosis and prompt institution of appropriate therapy.
Keating
M R
MR
Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Wilhelm
M P
MP
Walker
R C
RC
D016027:Heart Transplantation / Q000009:adverse effects; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000209:etiology; D011183:Postoperative Complications / Q000517:prevention & control*; D014019:Tissue Donors